TrialDiabetologia2026

Efficacy of tirzepatide versus semaglutide in achieving therapeutic targets in type 2 diabetes: a post hoc analysis of the SURPASS-2 Trial.

João Sérgio Neves et al.PubMed ↗Publisher ↗

No numbers read from the abstract.